JEFFREY BRADY: Open Payments
NPI 1467465716 · WAUKEE, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,420 in 131 payments from 20 companies in 2025. Trend: 2023 $1,903 · 2024 $2,340 · 2025 $2,420
Food & beverage: $2,408Education: $12
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 30 | $533 |
| AstraZeneca Pharmaceuticals LP | 18 | $331 |
| ABBVIE INC. | 19 | $310 |
| Lilly USA, LLC | 13 | $254 |
| Otsuka America Pharmaceutical, Inc. | 6 | $217 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $108 |
| Astellas Pharma US Inc | 6 | $107 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $94 |
| Phathom Pharmaceuticals, Inc. | 8 | $90 |
| Teva Pharmaceuticals USA, Inc. | 3 | $71 |
Products named: REXULTI, ELIQUIS, JARDIANCE, VRAYLAR, PAXLOVID, MOUNJARO, NURTEC ODT, Kerendia.
Industry payments across IA — which companies pay providers there.
